With the approval of the French Medicines Agency, medical experimentation on cannabis will concern 3,000 patients for a period of two years. Patients with chronic diseases will be admitted to 215 tertiary referral centers in 170 hospitals across the country.
Participate in the experience of hospitals that have been equipped with doctors specializing in pain, oncology, neurology, epilepsy, multiple sclerosis, palliative care trained for the purpose of the experiment, said Nathalie Richard, director of the Medical Cannabis project at the ‘ANSM Medicines. Agency.
According to the French Ministry of Health, the experiment aims to collect data on the effectiveness and safety of medical cannabis in the treatment of chronic diseases in order to pave the way for possible legalization.
French media reported that Health Minister Olivier Veran visited Clermont-Ferrand University Hospital to mark the first prescription of medical cannabis.
The experiment was originally scheduled to launch in September 2020 after the French parliament approved it in 2019, but it was delayed due to the spread of COVID-19 in the country.
Almost 20 countries in the European Union have already authorized treatments with medical cannabis.